AI assistant
Medtronic plc — Director's Dealing 2018
Sep 5, 2018
29841_dirs_2018-09-05_8671b8a5-2c28-4897-a2e2-abe2728396c1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2018-08-31
Reporting Person: HAKAMI HOOMAN (EVP & Group President Diabetes)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-31 | Ordinary Shares | M | 399 | $62.76 | Acquired | 63046 | Direct |
| 2018-08-31 | Ordinary Shares | M | 7436 | $62.76 | Acquired | 70482 | Direct |
| 2018-08-31 | Ordinary Shares | M | 18324 | $62.76 | Acquired | 88806 | Direct |
| 2018-08-31 | Ordinary Shares | S | 26159 | $96.288 | Disposed | 62647 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-31 | Stock Option (Right to Buy) | $62.76 | M | 399 | Disposed | 2024-07-28 | Ordinary Shares (399) | Direct |
| 2018-08-31 | Stock Option (Right to Buy) | $62.76 | M | 7436 | Disposed | 2024-07-28 | Ordinary Shares (7436) | Direct |
| 2018-08-31 | Stock Option (Right to Buy) | $62.76 | M | 18324 | Disposed | 2024-07-28 | Ordinary Shares (18324) | Direct |
Footnotes
F1: The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.04 to $96.44, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3: These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant.